It is well documented that HPV, specifically via the viral E6 oncoprotein, inactivates p53 [40], and that as a result TP53 mutations are highly unusual in HPV-driven tumours of the cervix and also oropharynx (2–3% of cases [16]). The gene discussed is TP53; the disease is neoplasm.